TScan Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| LYNX1 CAPITAL MANAGEMENT LP | 11/13/2025 | 7.86 M | $14.30 M | 0.00% | 6.06% |
| BVF INC/IL | 11/14/2025 | 5.23 M | $9.51 M | 0.00% | 4.03% |
| BAKER BROS. ADVISORS LP | 11/14/2025 | 2.78 M | $5.07 M | 0.00% | 2.15% |
| BLACKROCK, INC. | 11/12/2025 | 2.38 M | $4.34 M | -7.16% | 1.84% |
| VANGUARD GROUP INC | 11/07/2025 | 2.32 M | $4.22 M | 7.84% | 1.79% |
| PROPEL BIO MANAGEMENT, LLC | 11/12/2025 | 1.93 M | $3.52 M | -7.42% | 1.49% |
| ABRDN PLC | 11/07/2025 | 1.35 M | $2.47 M | 51.98% | 1.04% |
| DEER MANAGEMENT CO. LLC | 11/14/2025 | 1.25 M | $2.27 M | 0.00% | 0.96% |
| ALPHABET INC. | 11/07/2025 | 1.08 M | $1.96 M | 0.00% | 0.83% |
| SIMPLIFY ASSET MANAGEMENT INC. | 10/20/2025 | 904.97 K | $1.65 M | -13.56% | 0.70% |
| MORGAN STANLEY | 11/14/2025 | 847.54 K | $1.54 M | -0.68% | 0.65% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 829.92 K | $1.51 M | 4.78% | 0.64% |
| DC FUNDS, LP | 11/10/2025 | 630.00 K | $1.15 M | 0.00% | 0.49% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2025 | 600.00 K | $1.09 M | 0.00% | 0.46% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 567.66 K | $1.03 M | 0.23% | 0.44% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 466.09 K | $848.28 K | -26.03% | 0.36% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 419.40 K | $763.32 K | 14.89% | 0.32% |
| CITADEL ADVISORS LLC | 11/14/2025 | 390.75 K | $711.16 K | 78.43% | 0.30% |
| TWO SIGMA ADVISERS, LP | 11/14/2025 | 288.80 K | $525.62 K | 34.70% | 0.22% |
| JPMORGAN CHASE & CO | 11/26/2025 | 237.75 K | $432.71 K | -17.37% | 0.18% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 223.02 K | $405.90 K | 2.32% | 0.17% |
| STATE STREET CORP | 11/14/2025 | 197.31 K | $359.11 K | -1.60% | 0.15% |
| BROWN BROTHERS HARRIMAN & CO | 11/13/2025 | 143.05 K | $260.35 K | 0.00% | 0.11% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2025 | 140.40 K | $255.53 K | -8.65% | 0.11% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 130.98 K | $238.38 K | -69.54% | 0.10% |
| MILITIA CAPITAL PARTNERS, LP | 11/14/2025 | 102.10 K | $185.82 K | 8.27% | 0.08% |
| NORTHERN TRUST CORP | 11/14/2025 | 98.55 K | $179.36 K | 0.00% | 0.08% |
| STIFEL FINANCIAL CORP | 11/12/2025 | 97.40 K | $177.27 K | -15.99% | 0.08% |
| LETKO, BROSSEAU & ASSOCIATES INC | 11/12/2025 | 95.88 K | $174.49 K | 0.00% | 0.07% |
| NEWEDGE WEALTH, LLC | 11/07/2025 | 91.46 K | $103.81 K | 0.00% | 0.07% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 87.32 K | $158.72 K | -32.76% | 0.07% |
| JANE STREET GROUP, LLC | 11/14/2025 | 81.32 K | $148.00 K | -61.89% | 0.06% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 79.76 K | $145.16 K | -44.75% | 0.06% |
| VIRTU FINANCIAL LLC | 11/14/2025 | 60.48 K | $110.00 K | 431.09% | 0.05% |
| QUADRATURE CAPITAL LTD | 11/13/2025 | 56.67 K | $103.42 K | 151.85% | 0.04% |
| VOLEON CAPITAL MANAGEMENT LP | 11/14/2025 | 47.88 K | $87.14 K | 100.00% | 0.04% |
| MARSHALL WACE, LLP | 11/13/2025 | 46.63 K | $84.87 K | -13.13% | 0.04% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 11/14/2025 | 42.08 K | $76.58 K | -75.61% | 0.03% |
| DC INVESTMENTS MANAGEMENT, LLC | 11/10/2025 | 35.56 K | $64.73 K | 0.00% | 0.03% |
| CATALYST FUNDS MANAGEMENT PTY LTD | 11/12/2025 | 30.76 K | $55.99 K | 70.91% | 0.02% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 29.87 K | $54.36 K | 26.05% | 0.02% |
| ALGERT GLOBAL LLC | 11/14/2025 | 28.03 K | $51.00 K | 0.00% | 0.02% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2025 | 27.68 K | $50.37 K | -59.47% | 0.02% |
| HSBC HOLDINGS PLC | 11/13/2025 | 24.57 K | $43.87 K | -19.43% | 0.02% |
| LPL FINANCIAL LLC | 11/12/2025 | 21.50 K | $39.13 K | 100.00% | 0.02% |
| VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC | 10/31/2025 | 20.99 K | $38.21 K | 5.53% | 0.02% |
| BARCLAYS PLC | 11/12/2025 | 19.08 K | $34.72 K | -9.92% | 0.01% |
| R SQUARED LTD | 11/12/2025 | 18.83 K | $34.27 K | 68.38% | 0.01% |
| NEUBERGER BERMAN GROUP LLC | 11/12/2025 | 18.40 K | $33.49 K | -13.07% | 0.01% |
| XTX TOPCO LTD | 11/14/2025 | 17.63 K | $32.08 K | 100.00% | 0.01% |
TScan Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 89 institutional investors and hedge funds held shares of TScan Therapeutics, Inc.. The most heavily invested institutionals were:
Lynx1 Capital Management LP: 7.86 M
BVF INC/IL: 5.23 M
BAKER BROS. ADVISORS LP: 2.78 M
BlackRock, Inc.: 2.38 M
VANGUARD GROUP INC: 2.32 M
Propel Bio Management, LLC: 1.93 M
26.67% of TScan Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 40.60 M shares in the last 24 months. This purchase volume represents approximately $43.84 M in transactions.